Published by Josh White on 21st September 2016
(ShareCast News) - International specialty pharmaceutical company Midatech Pharma announced on Wednesday that its US subsidiary, Midatech Pharma US, has finalised a co-promotion agreement with R-Pharm US, providing additional reach and frequency for the promotion the of Zuplenz and Oravig products to oncology accounts across the US.